1985
DOI: 10.1016/s0022-5223(19)38661-1
|View full text |Cite
|
Sign up to set email alerts
|

Improved right ventricular function following late pulmonary valve replacement for residual pulmonary insufficiency or stenosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
41
0

Year Published

2003
2003
2014
2014

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 149 publications
(45 citation statements)
references
References 12 publications
4
41
0
Order By: Relevance
“…The procedure was approved by the Therapeutic Products Directorate, Department of Health and Welfare (Canada), and the United States Food and Drug Administration for compassionate clinical use in patients at high risk for surgery. Patients were considered for TPVI if they had congenital heart disease that had been surgically corrected with the use of a right ventricular outflow tract (RVOT) conduit, and evidence of conduit dysfunction as manifested by symptoms or conventional indications for surgical conduit revision [28–35]. Indications included right ventricular hypertension (>75% of systemic) due to conduit obstruction, significant pulmonary regurgitation (PR), and/or increased right ventricle end diastolic volume (>150 ml/m 2 ).…”
Section: Methodsmentioning
confidence: 99%
“…The procedure was approved by the Therapeutic Products Directorate, Department of Health and Welfare (Canada), and the United States Food and Drug Administration for compassionate clinical use in patients at high risk for surgery. Patients were considered for TPVI if they had congenital heart disease that had been surgically corrected with the use of a right ventricular outflow tract (RVOT) conduit, and evidence of conduit dysfunction as manifested by symptoms or conventional indications for surgical conduit revision [28–35]. Indications included right ventricular hypertension (>75% of systemic) due to conduit obstruction, significant pulmonary regurgitation (PR), and/or increased right ventricle end diastolic volume (>150 ml/m 2 ).…”
Section: Methodsmentioning
confidence: 99%
“…The results of the current study suggest that reduction of RV dilation and volume overload may prevent adverse interventricular interaction and subsequent LV dysfunction and fi brosis in patients after repair of TOF. Since pulmonary valve replacement among patients with hemodynamic relevant residual pulmonary valve regurgitation has been shown to positively infl uence RV size and volume overload, an appropriate timing of pulmonary valve replacement may also positively infl uence LV systolic function (25)(26)(27)(28)(29)(30).…”
Section: Comparison With Prior Studiesmentioning
confidence: 99%
“…Several studies reporting on patients who underwent PV replacement for PR in TOF have demonstrated improvement in the functional class, increased exercise tolerance, reduction in RV end diastolic diameter and volume, and at times, improvement in ejection fraction using echocardiography or CMR. 12,14,25,55,57,62,66,71,72 Bove et al 71 were the first to demonstrate that RV dysfunction associated with PR is reversible and that PV replacement should be carried out before permanent RV dysfunction ensues. An increase of more than 5% in RV ejection fraction was noted in 7 patients.…”
Section: Outcome Following Pv Replacementmentioning
confidence: 99%